About Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica
Clinical Trials at Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica
During the past decade, Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica"
#1 collaborator was "Istituto Nazionale Tumori di Napoli" with 1 trials as a collaborator and "Unità Sperimentazioni cliniche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica
According to Clinical.Site data, the most researched conditions in "Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica" are
"Non-Small Cell Lung Cancer" (2 trials), "Advanced Colorectal Cancer" (1 trials), "Colorectal Cancer (CRC)" (1 trials), "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Adenocarcinoma" (1 trials). Many other conditions were trialed in "Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica" in a lesser frequency.
Clinical Trials Intervention Types at Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica
Most popular intervention types in "Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Carboplatin" (2 trials), "Aflibercept, 5fluorouracil, Folinic Acid andIrinotecan" (1 trials), "Bemarituzumab" (1 trials) and "Carfilzomib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica
The vast majority of trials in "Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica" are
8 trials for "All" genders.
Clinical Trials Status at Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica
Currently, there are NaN active trials in "Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Presidio Ospedaliero Vito Fazzi; Unita Operativa Di Oncologia Medica, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".